Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome

Petrus J.W. Naudé*, Alain D. Dekker, Antonia M.W. Coppus, Yannick Vermeiren, Ulrich L.M. Eisel, Cornelia M. Van Duijn, Debby Van Dam, Peter P. De Deyn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum NGAL is Associated with Distinct Plasma Amyloid-β Peptides According to the Clinical Diagnosis of Dementia in Down Syndrome'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science